| Price | 3.72p on 26-06-2026 at 15:40:00 |
|---|---|
| Change | 0.02p 0.54% |
| Buy | 3.875p |
| Sell | 3.65p |
| Last Trade: | Sell 444.00 at 3.72p |
| Day's Volume: | 5,317,724 |
| Last Close: | 3.72p |
| Open: | 3.50p |
| ISIN: | GB0033711010 |
| Day's Range | 3.50p - 3.72p |
| 52wk Range: | 1.40p - 19.00p |
| Market Capitalisation: | £23.21m |
| VWAP: | 3.628155p |
| Shares in Issue: | 623.91m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Immupharma (IMM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 444 | 3.72p | Uncrossing Trade |
16:35:27 - 26-Jun-26 |
| Sell* | 25,094 | 3.661p | Ordinary |
16:26:40 - 26-Jun-26 |
| Buy* | 2,265 | 3.8255p | Ordinary |
16:24:57 - 26-Jun-26 |
| Buy* | 6,535 | 3.8255p | Ordinary |
16:19:53 - 26-Jun-26 |
| Buy* | 112,223 | 3.8299p | Ordinary |
15:48:37 - 26-Jun-26 |
| Sell* | 250,000 | 3.7367p | Ordinary |
15:47:11 - 26-Jun-26 |
| Buy* | 30,009 | 3.72p | Automatic Execution |
15:43:33 - 26-Jun-26 |
| Buy* | 377 | 3.72p | SI Trade |
15:43:30 - 26-Jun-26 |
| Buy* | 50,000 | 3.70p | Ordinary |
15:42:55 - 26-Jun-26 |
| Buy* | 250,000 | 3.6821p | Ordinary |
15:33:59 - 26-Jun-26 |
Immupharma (IMM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 25th Jun 2026 1:20 pm | RNS | 2026 RESULT OF ANNUAL GENERAL MEETING |
| 25th Jun 2026 7:00 am | RNS | ImmuPharma appoints Bachem for Kapiglucagon API |
| 24th Jun 2026 7:00 am | RNS-R | University of Murcia research relating to P140 |
| 4th Jun 2026 7:10 am | RNS-R | Incanthera plc – Corporate Update & Board Changes |
| 2nd Jun 2026 7:00 am | RNS | Notice of AGM & Annual Report & Accounts |
| 27th May 2026 7:00 am | RNS | Final Results |
| 5th May 2026 7:00 am | RNS | IMM initiatesIND-Enabling Program for Kapiglucagon |
| 10th Apr 2026 7:00 am | RNS | Holding(s) in Company |
| 9th Apr 2026 7:00 am | RNS-R | Chairman’s Open Letter to Shareholders |
| 7th Apr 2026 11:45 am | RNS | Result of General Meeting and TVR |
